Stiff Biosimilar Headwinds To Negatively Impact Amgen's Aging Drug Portfolio
June 29, 2016 at 12:07 PM EDT
Bernstein's Aaron Gal initiated Amgen, Inc. (NASDAQ: AMGN) at Market Perform and set a price target of $161. The company will have a ...
